Steatotic liver disease spectrum: From MASLD to MetALD and beyond - Clinical outcomes and precision medicine frontiers
Won Kim · 2026
Read Steatotic liver disease spectrum: From MASLD to MetALD and beyond - Clinical outcomes and precision medicine frontiers by Won Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13641678.txt.
Description
Won Kim reviews a fast-moving field in a 2026 survey of fatty liver disease and its new naming scheme. A 2023 agreement among expert groups replaced the old name for the illness. The new frame groups cases by cause: those tied to body metabolism, those tied to both metabolism and drink, and those tied to drink alone.
Three years on, the hard questions are about daily use. How common is each type, and how well can doctors tell them apart at the bedside? Which genes and body paths push one person toward harm while another stays stable? The review also weighs how drink intake should be measured and folded into risk scores. It closes with where tailored care for each patient may head next.
Catalog record
| CREATOR | Won Kim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |